Uncategorized

Own the Clock: How Pharma Companies Extract Maximum Value from Patent Term Extensions and Secondary Patents

Pharma’s real clock isn’t the one on the label—it’s the one in the patent office.
Most people think patent life is a straight line: file, wait, expire. In reality, the industry plays a more sophisticated game—one where timing, regulatory strategy, and …

Own the Clock: How Pharma Companies Extract Maximum Value from Patent Term Extensions and Secondary Patents Read Post »

Uncategorized

Pick the Right FDA Pathway and You Own the Market. Pick the Wrong One and You’re Funding Your Competitor.

Pick the Right FDA Pathway—and You Own the Market. Pick the Wrong One—and You’re Funding Your Competitor.
Most pharma strategy conversations start with molecules. The best ones start with regulatory math.
Because in today’s market, the FDA pathway you …

Pick the Right FDA Pathway and You Own the Market. Pick the Wrong One and You’re Funding Your Competitor. Read Post »

Biotechblog
Scroll to Top